URGN
UroGen Pharma Ltd.
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $250M | +56.2% |
| Gross profit | $229M | +55.3% |
| Operating income | −$31M | — |
| Net income | −$66M | — |
| EPS | −$1.32 | — |
| Free cash flow | −$132M | — |
UroGen Pharma Ltd.
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $250M | +56.2% |
| Gross profit | $229M | +55.3% |
| Operating income | −$31M | — |
| Net income | −$66M | — |
| EPS | −$1.32 | — |
| Free cash flow | −$132M | — |